Arbutus Biopharma (ABUS) EBITDA Margin (2015 - 2026)
Arbutus Biopharma (ABUS) recorded EBITDA Margin of -587.08% in Q2 2026, down 601.04 percentage points from 13.96% a year earlier and down 681.38 percentage points from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) EBITDA Margin (2015 - 2026) Analysis & Trends
On a TTM basis, Arbutus Biopharma's EBITDA Margin came in at 85.75% as of Jun 30, 2026, up 515.18 percentage points year-over-year; for FY2025, it came in at -268.12%, up 945.92 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +539.02 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -1214.05% in FY2024 (-791.26 pp), -422.79% in FY2023 (-258.70 pp), -164.10% in FY2022 (+488.63 pp) and -652.73% in FY2021 (+154.41 pp).
- Quarterly EBITDA Margin has ranged from -1634.78% in Q3 2025 to 94.30% in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in two of the last six quarters, with an average year-over-year change of +132.98 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 1532.45 percentage points in Q1 2026, against a drop of 1121.21 percentage points in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | -587.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -587.08% |
| Mar 31, 2026 | 94.30% |
| Sep 30, 2025 | -1,634.78% |
| Jun 30, 2025 | 13.96% |
| Mar 31, 2025 | -1,438.15% |
| Sep 30, 2024 | -1,576.10% |
| Jun 30, 2024 | -1,229.84% |
| Mar 31, 2024 | -1,240.73% |
| Sep 30, 2023 | -454.89% |
| Jun 30, 2023 | -387.94% |
| Mar 31, 2023 | -255.41% |
| Sep 30, 2022 | -293.48% |
| Jun 30, 2022 | -96.38% |
| Mar 31, 2022 | -84.10% |
| Dec 31, 2021 | -633.87% |
| Sep 30, 2021 | -537.75% |
| Jun 30, 2021 | -781.71% |
| Mar 31, 2021 | -720.92% |
| Dec 31, 2020 | -661.86% |
| Sep 30, 2020 | -966.97% |
API Access
Arbutus Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();